LEAVITT PARTNERS, LLC

Lobbying for SICKLE CELL DISEASE PARTNERSHIP · Alliance of patient advocates, plans, providers & manufacturers focused on federal policy.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $30,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Health Issues

Sickle cell disease focused legislation, federal funding, and federal programs.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.